ANGELICA AGUILAR: Open Payments
NPI 1023316114 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 19 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $64 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $389 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Organon LLC | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
Products named: DUPIXENT, Rhapsido, ALVESCO, AIRSUPRA, NEFFY, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
